Follicular Lymphoma: Refining Prognostic Models and Impact of Pod-24 in Clinical Outcomes
- 1 February 2022
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 22 (2) , 67-75
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studiesThe Lancet Haematology, 2014
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationJournal of Clinical Oncology, 2014
- The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)Annals of Oncology, 2014
- A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—TositumomabClinical Cancer Research, 2013
- Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practicesAnnals of Oncology, 2012
- Positron Emission Tomography–Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial ParticipantsJournal of Clinical Oncology, 2011
- Prognostic relevance of serum 2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL studyHaematologica, 2007
- The International Harmonization Project for Response Criteria in Lymphoma Clinical TrialsHematology/Oncology Clinics of North America, 2007
- Follicular Lymphoma International Prognostic IndexBlood, 2004
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993